Literature DB >> 18452786

Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction.

Joseph G Akar1, Walter Jeske, David J Wilber.   

Abstract

OBJECTIVES: The purpose of this study was to determine whether acute onset atrial fibrillation (AF), independent of other risk factors, predisposes to an early prothrombotic state.
BACKGROUND: Several risk factors predispose to the hypercoagulable state in human AF, but whether acute onset AF alone is prothrombotic remains unclear.
METHODS: Patients with paroxysmal AF (n = 22) underwent radiofrequency catheter ablation. All patients presented in sinus rhythm. Baseline blood samples were obtained simultaneously from the femoral vein (systemic sample) and the coronary sinus (local cardiac sample). The AF was induced by burst atrial pacing in 14 patients (AF group). A control group (n = 8) underwent atrial pacing at 120 beats/min. Blood samples were recollected after 15 min. Platelet P-selectin expression (CD62) was measured using flow cytometry. Markers of thrombin generation (thrombin antithrombin complex, prothrombin fragment 1.2), inflammation (C-reactive protein, interleukin-6), and nitric oxide were measured using enzyme-linked immunosorbent assays.
RESULTS: Neither local nor systemic platelet activation changed in the control group. In the AF group, local cardiac platelet activation (percent P-selectin [+] platelets) increased significantly (2.2 +/- 0.6% to 2.8 +/- 1.0%, p = 0.007); however, systemic platelet activation did not change. The AF group had increased local thrombin generation (thrombin antithrombin complex: 8.5 +/- 7.6 ng/ml to 33.2 +/- 17.4 ng/ml, p = 0.003; prothrombin fragment 1.2: 95.6 +/- 45.6 micromol/l to 243.8 +/- 120.1 micromol/l, p = 0.003), decreased nitric oxide production (25.2 +/- 10.8 micromol/l to 22.3 +/- 10.0 micromol/l, p < 0.02), and no change in inflammatory markers.
CONCLUSIONS: Human AF causes local cardiac platelet activation within minutes of onset. The results demonstrate how AF alone, independent of other risk factors, may contribute to the hypercoagulable state.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18452786     DOI: 10.1016/j.jacc.2007.11.083

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  29 in total

1.  The risk of myocardial infarction in patients with atrial fibrillation: an unresolved issue.

Authors:  Licia Polimeni; Ludovica Perri; Mirella Saliola; Stefania Basili; Francesco Violi
Journal:  Intern Emerg Med       Date:  2010-03-03       Impact factor: 3.397

Review 2.  EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication.

Authors:  Andreas Goette; Jonathan M Kalman; Luis Aguinaga; Joseph Akar; Jose Angel Cabrera; Shih Ann Chen; Sumeet S Chugh; Domenico Corradi; Andre D'Avila; Dobromir Dobrev; Guilherme Fenelon; Mario Gonzalez; Stephane N Hatem; Robert Helm; Gerhard Hindricks; Siew Yen Ho; Brian Hoit; Jose Jalife; Young-Hoon Kim; Gregory Y H Lip; Chang-Sheng Ma; Gregory M Marcus; Katherine Murray; Akihiko Nogami; Prashanthan Sanders; William Uribe; David R Van Wagoner; Stanley Nattel
Journal:  Heart Rhythm       Date:  2016-06-10       Impact factor: 6.343

3.  Growth differentiation factor 15 is associated with left atrial/left atrial appendage thrombus in patients with nonvalvular atrial fibrillation.

Authors:  Xiao Feng Hu; Rui Zhan; Shanhu Xu; Junjun Wang; Jiong Wu; Xiaoli Liu; Yaguo Li; Linhui Chen
Journal:  Clin Cardiol       Date:  2018-01-24       Impact factor: 2.882

Review 4.  Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.

Authors:  Francesco Violi; Gregory Y H Lip; Stefania Basili
Journal:  Intern Emerg Med       Date:  2011-06-11       Impact factor: 3.397

Review 5.  Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.

Authors:  Abhishek Maan; Amir Y Shaikh; Moussa Mansour; Jeremy N Ruskin; E Kevin Heist
Journal:  J Atr Fibrillation       Date:  2012-06-15

Review 6.  Role of Inflammation in Initiation and Perpetuation of Atrial Fibrillation: A Systematic Review of the Published Data.

Authors:  Karen P Phillips
Journal:  J Atr Fibrillation       Date:  2013-10-31

7.  Advanced age, low left atrial appendage velocity, and factor V promoter sequence variation as predictors of left atrial thrombosis in patients with nonvalvular atrial fibrillation.

Authors:  Dmitry A Zateyshchikov; Alexey N Brovkin; Dimitry A Chistiakov; Valery V Nosikov
Journal:  J Thromb Thrombolysis       Date:  2010-08       Impact factor: 2.300

8.  Atrial fibrillation and the risk of myocardial infarction.

Authors:  Elsayed Z Soliman; Monika M Safford; Paul Muntner; Yulia Khodneva; Farah Z Dawood; Neil A Zakai; Evan L Thacker; Suzanne Judd; Virginia J Howard; George Howard; David M Herrington; Mary Cushman
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

9.  Left ventricular native T1 time and the risk of atrial fibrillation recurrence after pulmonary vein isolation in patients with paroxysmal atrial fibrillation.

Authors:  Shingo Kato; Murilo Foppa; Sébastien Roujol; Tamer Basha; Sophie Berg; Kraig V Kissinger; Beth Goddu; Warren J Manning; Reza Nezafat
Journal:  Int J Cardiol       Date:  2015-11-11       Impact factor: 4.164

Review 10.  Evaluating the Atrial Myopathy Underlying Atrial Fibrillation: Identifying the Arrhythmogenic and Thrombogenic Substrate.

Authors:  Jeffrey J Goldberger; Rishi Arora; David Green; Philip Greenland; Daniel C Lee; Donald M Lloyd-Jones; Michael Markl; Jason Ng; Sanjiv J Shah
Journal:  Circulation       Date:  2015-07-28       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.